CASP3 and neoplasm: However, assessment of tumour cell proliferation and apoptosis in these mice revealed that a low dose of dasatinib did not significantly affect the levels of Ki-67 and cleaved caspase-3 (Fig. 7k and Extended Data Fig. 9g).